Event Brief
Jul 16, 2026 at 9:00 AM ET
Eli Lilly to buy AtaiBeckley for $2.8 billion
By The BriefBrief
Eli Lilly agreed to acquire AtaiBeckley for $2.8 billion to access experimental DMT and MDMA-based treatments.
WHO: Eli Lilly
WHAT: Agreed to acquire AtaiBeckley for $2.8 billion
WHEN: Jul 16, 2026 at 6:48 AM ET
WHERE: Location not specified
WHY: To gain access to AtaiBeckley’s experimental drugs based on DMT and MDMA.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
TSMC posts record profit and pledges $100bn US expansion
Tsmc
Jul 16, 2026 at 9:00 AM ET
US clears nearly $2B in precision weapons for Saudi
Us
Jul 16, 2026 at 9:00 AM ET
Quarantine approach to Taiwan avoids missile-barrage scenario
Iran
Jul 16, 2026 at 9:00 AM ET
Xona plans 258 low-Earth-orbit satellites as GPS alternative
Xona
Jul 16, 2026 at 9:00 AM ET
Page 12743 of 21449
Same format. Every time.
Continue reading — sign in or create a free account with
